Pre-Open Stock Movers 04/18: Casa Systems and Natus Medical Higher; TG Therapeutics and Nektar Lower (more...)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
TG Therapeutics (TGTX) PT Lowered to $19 at Jefferies
April 19, 2022 8:36 AM EDTJefferies analyst Chris Howerton lowered the price target on TG Therapeutics (NASDAQ: TGTX) to $19.00 (from $46.00) while maintaining a Buy rating.
The analyst commented, "During Monday morning's press conference TG announced it's pausing its oncology programs. The decision was made based on updated... More
Northland Capital Markets Upgrades Casa Sytems, Inc. (CASA) to Outperform as Verizon Win is 'Game Changing'
April 19, 2022 7:48 AM EDTNorthland Capital Markets analyst Tim Savageaux upgraded Casa Sytems, Inc. (NASDAQ: CASA) from Market Perform to Outperform with a price target of $10 following the Verizon win which it called "game changing."
The analyst commented, "After years of engagement and trials with... More
Synchrony Financial (SYF) PT Raised to $52 at BMO Capital
April 19, 2022 7:36 AM EDTBMO Capital analyst James Fotheringham raised the price target on Synchrony Financial (NYSE: SYF) to $52.00 (from $49.00) while maintaining a Outperform rating following results.
The analyst commented, "Following SYFs 1Q22 broad-based beat, we raise estimates by up to 6% (better NII and credit) and increase our... More

